cbdMD Inc (YCBD)
0.699
-0.02
(-2.52%)
USD |
NYAM |
May 21, 16:00
0.69
-0.01
(-1.29%)
After-Hours: 20:00
cbdMD Enterprise Value: 3.306M for May 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 21, 2024 | 3.306M |
| May 20, 2024 | 3.376M |
| May 17, 2024 | 3.370M |
| May 16, 2024 | 3.349M |
| May 15, 2024 | 3.334M |
| May 14, 2024 | 2.764M |
| May 13, 2024 | 2.688M |
| May 10, 2024 | 2.660M |
| May 09, 2024 | 2.858M |
| May 08, 2024 | 2.946M |
| May 07, 2024 | 3.047M |
| May 06, 2024 | 3.19M |
| May 03, 2024 | 3.227M |
| May 02, 2024 | 3.281M |
| May 01, 2024 | 3.434M |
| April 30, 2024 | 3.951M |
| April 29, 2024 | 3.333M |
| April 26, 2024 | 3.254M |
| April 25, 2024 | 3.342M |
| April 24, 2024 | 3.342M |
| April 23, 2024 | 3.373M |
| April 22, 2024 | 3.571M |
| April 19, 2024 | 3.647M |
| April 18, 2024 | 3.644M |
| April 17, 2024 | 3.403M |
| Date | Value |
|---|---|
| April 16, 2024 | 3.375M |
| April 15, 2024 | 3.484M |
| April 12, 2024 | 3.388M |
| April 11, 2024 | 3.708M |
| April 10, 2024 | 3.647M |
| April 09, 2024 | 3.586M |
| April 08, 2024 | 3.677M |
| April 05, 2024 | 3.345M |
| April 04, 2024 | 3.530M |
| April 03, 2024 | 3.342M |
| April 02, 2024 | 3.379M |
| April 01, 2024 | 3.220M |
| March 31, 2024 | 3.434M |
| March 28, 2024 | 1.332M |
| March 27, 2024 | 1.576M |
| March 26, 2024 | 1.637M |
| March 25, 2024 | 1.271M |
| March 22, 2024 | 1.271M |
| March 21, 2024 | 0.7825M |
| March 20, 2024 | 0.7292M |
| March 19, 2024 | 0.7261M |
| March 18, 2024 | 0.8449M |
| March 15, 2024 | 0.586M |
| March 14, 2024 | 0.7069M |
| March 13, 2024 | 0.6317M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-0.0433M
Minimum
Oct 31 2023
301.50M
Maximum
Feb 10 2021
61.90M
Average
39.87M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 5.64M |
| Palatin Technologies Inc | 23.39M |
| iBio Inc | 28.48M |
| Theriva Biologics Inc | -8.913M |
| Oragenics Inc | 13.27M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.011M |
| Revenue (Quarterly) | 4.376M |
| Total Expenses (Quarterly) | 5.928M |
| EPS Diluted (Quarterly) | -1.35 |
| Gross Profit Margin (Quarterly) | 58.97% |
| Profit Margin (Quarterly) | -68.79% |
| Earnings Yield | -1.75K% |
| Normalized Earnings Yield | -1016.45 |